Metabolic Resolution of Lytic Lesions in Erdheim-Chester Disease on 18F-FDG PET/CT
- PMID: 32604106
- DOI: 10.1097/RLU.0000000000003118
Metabolic Resolution of Lytic Lesions in Erdheim-Chester Disease on 18F-FDG PET/CT
Abstract
Erdheim-Chester disease (ECD) is a rare non-Langerhans cell histiocytic disorder with variable clinical presentation most commonly involving the skeletal system. The long bones are the most common site of involvement giving a characteristic bone scintigraphy pattern of increased bilateral symmetric uptake in metadiaphyseal regions. We describe the findings of serial F-FDG PET/CT in a 16-year-old adolescent girl with ECD, emphasizing the role of F-FDG PET/CT in response assessment of ECD.
References
-
- Spyridonidis TJ, Giannakenas C, Barla P, et al. Erdheim-Chester disease: a rare syndrome with a characteristic bone scintigraphy pattern. Ann Nucl Med. 2008;22:323–326.
-
- Namwongprom S, Núñez R, Kim EE, et al. Tc-99m MDP bone scintigraphy and positron emission tomography/computed tomography (PET/CT) imaging in Erdheim-Chester disease. Clin Nucl Med. 2007;32:35–38.
-
- Martineau P, Pelletier-Galarneau M, Zeng W. The imaging findings of Erdheim-Chester disease: a multimodality approach to diagnosis and staging. World J Nucl Med. 2017;16:71–74.
-
- Chong VC, Tan CL, Chee YL, et al. A young patient with a lytic skull lesion. J Clin Pathol. 2018;71:1128.
-
- Ivan D, Neto A, Lemos L, et al. Erdheim-Chester disease: a unique presentation with liver involvement and vertebral osteolytic lesions. Arch Pathol Lab Med. 2003;127:e337–e339.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
